Low energy availability reduces bone mass and gonadal function in male mice
- 13 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 41 (2) , 182-192
Abstract
Introduction In women, the female athlete triad, marked by low energy availability, functional hypothalamic amenorrhea and osteoporosis, is a recognized risk for stress fractures. Stress injuries also occur in men, but by contrast risks and mechanisms underlying them are less characterized. Materials and methods 5 week-old wild-type male mice were fed ad libitum (ad) or subjected to 60% food restriction (FR) for five weeks. In both groups, some mice were allowed access to an exercise wheel in cages to allow voluntary wheel running (ex) and/or treated with active vitamin D analogues. Mice were sacrificed and analyzed at 10 weeks of age. Result Male FR mice exhibited significantly reduced testicle weight, serum testosterone levels and bone mass. Such bone losses in FR male mice were enhanced by exercise. Histological analysis revealed that both bone-resorbing and -forming activities were significantly reduced in FR or FR plus exercise (FR + ex) mice, mimicking a state of low bone turnover. Significantly reduced bone mass in FR or FR + ex male mice was significantly rescued by treatment with active vitamin D analogues, with significant restoration of osteoblastic activities. Serum levels of insulin-like growth factor I (IGF-I), which is critical for bone remodeling, were significantly lower in FR versus control male mice. Conclusions Low energy availability puts men at risk for stress injuries as well, and low energy availability is upstream of gonadal dysfunction and osteoporosis in males. Active vitamin D analogues could serve as therapeutic or preventive options for stress injuries in men.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
This publication has 43 references indexed in Scilit:
- HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosisProceedings of the National Academy of Sciences, 2013
- Update on the female athlete triadCurrent Reviews in Musculoskeletal Medicine, 2013
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cellsNature Medicine, 2012
- Bone health management in prostate cancer patients receiving androgen deprivation therapyJournal of Oncology Pharmacy Practice, 2011
- Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controlsBone, 2009
- Weight-bearing exercise and bone mineral accrual in children and adolescents: A review of controlled trialsBone, 2007
- Stress fractures: Pathophysiology, epidemiology, and risk factorsCurrent Osteoporosis Reports, 2006
- Bone Quality — The Material and Structural Basis of Bone Strength and FragilityNew England Journal of Medicine, 2006
- Bone Loss and Bone Size after MenopauseNew England Journal of Medicine, 2003